MK-3697 Size:Solid 10 mg 19R)-11-(acetyloxy)-4-[(12S

19R)-11-(acetyloxy)-4-[(12S

Naringin Dihydrochalcone(Naringin DC) is a new-style sweetening agent and an artificial sweetener derived from naringin

This may result in an induction of chromatin remodeling

in which Src family kinases and CDKs are activated

MK-3697 Size:Solid 10 mg 19R)-11-(acetyloxy)-4-[(12SMK 3697 is a highly potent, orally bioavailable selective orexin 2 receptor antagonists . MK 3697 is also the third insomnia drug, currently being developed by Merck. MK 3697 has Ki = 0. 95 nM. Orexin receptor antagonists have demonstrated clinical utility for the treatment of insomnia. In vivo tests results on MK 3697 demonstrated improved stability and TDI profiles as well as excellent sleep efficacy across species. Product information CAS Number: